Table 1.
Year of gene discovery | Disease* | N patients** | M/F ratio | Ethnicity*** | Ref | Mode of inheritance | Gene**** | Chromosome location | Most frequent mutation | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2008 |
H Syndrome |
Histiocytosis lymphadenopathy plus syndrome |
4 |
2/2 |
1 Indian case |
12 |
Recessive |
SLC29A3 |
Solute Carrier Family |
10q22.1 |
ND |
1 Pakistani case |
13 |
||||||||||
1 Morocan case |
10 |
29 (Nucleoside Transporter), Member 3 |
|||||||||
1 Tunisian case |
11 |
||||||||||
2008 |
NAPS12 |
NLRP12 Associated Periodic Syndrome |
19 |
13/6 |
2 Guadeloupean families |
18 |
Dominant |
NLRP12 |
NLR pyrin domain containing protein 12 |
19q43.42 |
c.1054C>T, p.Arg352Cys |
17 | |||||||||||
1 Italian family |
58 |
||||||||||
6 Eastern-European cases |
16 |
||||||||||
1 Armenian case |
16 |
||||||||||
1 Italian case |
9 |
||||||||||
1 Guadeloupean case |
9 |
||||||||||
1 Irish case | |||||||||||
2009 |
DIRA |
Deficiency of Interleukin 1 Receptor Antagonist |
17 |
9/8 |
1 Turkish family |
23 |
Recessive |
IL1RN |
Interleukin 1 |
2q13 |
c.-64_1696del, p.IL1F9_IL1RNdel |
1 Lebanese |
22 |
receptor antagonist |
|||||||||
family |
22 |
||||||||||
2 Dutch families |
22 |
c.213_227del, p.Asp72_Ile76del |
|||||||||
1 Dutch case |
22 |
||||||||||
1 Canadian case |
22,27 |
||||||||||
2 Puerto-Rican cases |
25 |
||||||||||
2 Brazilian cases |
24,26 |
||||||||||
2 Unknown | |||||||||||
3 Dutch, | |||||||||||
1 Lebanese, | |||||||||||
1 Turkish, | |||||||||||
1 from unknown ancestry | |||||||||||
2011 |
DITRA |
Deficiency of Interleukin |
66 |
26/37 |
3 Tunisian families |
30 |
Recessive |
IL36RN |
Interleukin 36 receptor antagonist |
2q13 |
c.80C>T, p.Leu27Pro |
1 Algerian family |
9 |
||||||||||
36 Receptor Antagonist |
19 European cases |
32,35,37 |
c.338C>T, p.Ser113Leu |
||||||||
10 Asian cases |
35 |
c.28C>T, p.Arg10* |
|||||||||
6 Tunisian cases |
30 |
||||||||||
6 German cases |
36 |
||||||||||
3 Japanese cases |
33,34 |
||||||||||
1 Spanish case |
9 |
||||||||||
1 Turkish case |
36 |
||||||||||
1 Iraqi case |
36 |
||||||||||
1 Russian case |
37 |
||||||||||
2012 |
PSORS2 |
Psoriasis susceptibility 2 |
45 |
24/21 |
1 European family |
42 |
Dominant |
CARD14 |
Caspase recruitment domain-containing protein 14 |
17q25.3 |
c.349G>A, p.Gly117Ser |
1 Taiwanese family |
42 |
||||||||||
1 Tunisian family |
43 |
||||||||||
3 German cases |
36 |
||||||||||
|
PRP |
Pityriasis Rubra Pilaris |
17 |
9/8 |
4 Israeli families |
41 |
|||||
2012 |
DSAP |
Disseminated Superficial Actinic Porokeratosis |
>45 |
21/16/ND |
20 Chinese families, |
48.49 |
Dominant |
MVK |
Mevalonate Kinase |
12q24 |
C.604G>A |
p.Gly202Arg | |||||||||||
6 Chinese cases | |||||||||||
2010 |
ALDD (JMP, NNS, CANDLE) |
Autoinflammation, lipodystrophy, and dermatosis syndrome |
40 |
26/14 |
22 Japanese families |
53,57 |
Recessive |
PSMB8 |
Proteasome Subunit, |
6p21.32 |
c.224C>T, p.Thr75Met |
1 Portuguese family |
56 |
Beta-Type, 8 |
c.602G>T, |
||||||||
1 Mexican family |
56 |
p.Gly201Val |
|||||||||
3 Hispanic cases |
54 |
||||||||||
3 Spanish cases |
54 |
||||||||||
2 American cases |
54 |
||||||||||
1 Japanese case |
53 |
||||||||||
1 Israeli case |
54 |
||||||||||
1 Italian case |
9 |
||||||||||
2012 |
APLAID |
Autoinflammation, Antibody deficiency, and Immune Dysregulation syndrome |
2 |
1/1 |
1 family of unknown origin |
14 |
Dominant |
PLCG2 |
Phospholipase C, gamma 2 |
16q23.3 |
ND |
2012 | NA | Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis | 3 | 1/2 | 1 French family |
15 | Recessive | RBCK1 | RANBP-Type and C3HC4-Type Zinc Finger-Containing 1 | 20p13 | ND |
1 Italian case |
* Commonly used disease names as defined in Table 2 ** Genetically confirmed. *** “Family” refers to multiplex families; “Case” refers to sporadic patients **** Approved HUGO.
NA: Not assigned yet. ND: Not determined.